|Bid||164.49 x 800|
|Ask||164.50 x 900|
|Day's Range||164.39 - 165.86|
|52 Week Range||133.65 - 173.65|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||29.06|
|Earnings Date||Jul 21, 2021|
|Forward Dividend & Yield||4.24 (2.57%)|
|Ex-Dividend Date||May 24, 2021|
|1y Target Est||186.65|
Yahoo Finance’s Alexis Keenan reports the latest on vaccination mandates and bans on vaccination proof.
The U.S. Food and Drug Administration on Tuesday authorized around 14 million more doses of Johnson & Johnson's COVID-19 vaccine manufactured at a problem-plagued Baltimore factory, according to two sources familiar with the plans. The FDA confirmed it had authorized a batch of the one-dose vaccine made at Emergent BioSolutions Inc's plant, but did not say how many doses were in the batch. All the J&J doses authorized from the plant to date are expected to be exported to other countries, one of the sources said.
South African President Cyril Ramaphosa said on Tuesday that Johnson & Johnson would send 2 million COVID-19 vaccine doses to the country by the end of the month, making up for the amount lost due to contamination at an U.S. ingredient supplier. Aspen Pharmacare, J&J's local producer, had to destroy 2 million doses of the vaccine after the contamination at a plant in Baltimore, Maryland, was discovered, the latest blow to South Africa's struggling vaccination campaign. "We have received an indication from Johnson & Johnson that it expects to deliver around 2 million vaccines to South Africa by the end of the month," Ramaphosa said in a televised address.